For instance, a combination of inhibitors to IGFR and CDK4/6 profoundly repressed the PI3K/mTOR pathway and had a synergistic anti-tumor effect in vitro and in vivo in EwS.184. This evidence concerns the gene CDK4 and neoplasm.